The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines
Open accessAbstract
The action of androgens is essential for the development of benign prostatic hyperplasia and carcinoma of the prostate. The androgen receptor is a ligand-dependent nuclear transcription factor. The transcriptional activation domain of the androgen receptor gene contains a polymorphic CAG repeat sequence. A shorter CAG repeat sequence within the normal range has been reported to be associated with increased risk of prostate cancer and symptomatic benign prostatic hyperplasia. Here, we examine the in vitro transcriptional activity of the androgen receptor (AR) with different numbers of CAG repeats within the normal range in a number of different cell lines of prostatic (LNCaP, PC3) and non-prostatic (COS-1, MCF7) origin. We utilize a luciferase reporter driven by the rat probasin promoter (-286/+28) containing two androgen receptor binding sites. Transcriptional activation of the androgen responsive reporter was observed to be greater with the AR containing 15 vs 31 CAG repeats in COS-1 cells (123.2+/-16.6 vs 78.2+/-10.9, P value 0.01) and the well differentiated prostate cancer cell line LNCaP (103.4+/-17.7 vs 81.4+/-7.7, P value 0.045). No difference was observed in the poorly differentiated prostate cancer cell line, PC3 (106.9+/-21.9 vs 109. 6+/-21.4, P>0.5) or the breast cancer cell line MCF7 (120.4+/-39.4 vs 103.1+/-23.1, P value >0.5). Dose-response experiments with varying quantities of ligand (0.01, 0.1, 1 and 10 nM dihydrotestosterone) or AR cDNA did not demonstrate significant differences in transactivation of the androgen responsive reporter in PC3 cells by the different AR constructs. This suggests that the lack of influence of CAG number in this prostatic cell line is not related to dose of ligand or quantity of androgen receptor. Western immunoblot analysis of androgen receptor protein in transiently transfected COS-1 cells did not demonstrate a difference in the expression of the androgen receptor protein with different numbers of CAG repeats following incubation in the presence or absence of androgen. Gel shift assay did not demonstrate increased DNA binding by androgen receptor with a shorter CAG repeat sequence. These experiments using a relatively androgen- and prostate-specific reporter provide evidence for an inverse relationship between androgen receptor transcriptional activity and the number of CAG repeats in the transcriptional activation domain. The effect of CAG repeat number was cell specific suggesting the involvement of accessory factors expressed differentially between different cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Proceedings of the National Academy of Sciences, USA
(1996) · Current Biology · doi:10.1016/s0960-9822(09)00431-x · Cited by 5,258
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. R. L., Wilson, E. M., Lubahn, D. B., Harding, A. E., & Fischbeck, K. H. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,784
SV40-transformed simian cells support the replication of early SV40 mutants
Gluzman, Y. (1981) · Cell · doi:10.1016/0092-8674(81)90282-8 · Cited by 2,372
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,123
Molecular and cellular endocrinology
(1995) · Journal of Endocrinology · doi:10.1677/joe.0.147so19 · Cited by 1,991
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
QUIGLEY, C. A., BELLIS, A. D., MARSCHKE, K. B., EL-AWADY, M. K., WILSON, E. M., & FRENCH, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,447
The Journal of Steroid Biochemistry and Molecular Biology
(2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(11)00143-9 · Cited by 1,234
Chamberlain, N. L., Driver, E. D., & Miesfeld, R. L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3181 · Cited by 1,156
Luciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., & Kantoff, P. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3320 · Cited by 873
Glass, C. K., Rose, D. W., & Rosenfeld, M. G. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80066-x · Cited by 698
Payvar, F., DeFranco, D., Firestone, G. L., Edgar, B., Wrange, Ö., Okret, S., Gustafsson, J.-Å., & Yamamoto, K. R. (1983) · Cell · doi:10.1016/0092-8674(83)90171-x · Cited by 678
Ingles, S. A., Ross, R. K., Yu, M. C., Haile, R. W., Irvine, R. A., La Pera, G., & Coetzee, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.166 · Cited by 583
Tut, T. G., Ghadessy, F. J., Trifiro, M. A., Pinsky, L., & Yong, E. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4385 · Cited by 512
Kazemi-Esfarjani, P., Trifiro, M. A., & Pinsky, L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.4.523 · Cited by 443
Androgen Receptor Localization in Different Cell Types of the Adult Rat Prostate*
PRINS, G. S., BIRCH, L., & GREENE, G. L. (1991) · Endocrinology · doi:10.1210/endo-129-6-3187 · Cited by 436
Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419
Cleutjens, K. B. J. M., van Eekelen, C. C. E. M., van der Korput, H. A. G. M., Brinkmann, A. O., & Trapman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6379 · Cited by 406
Tut, T. G. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3777 · Cited by 358
Mhatre, A. N., Trifiro, M. A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G., & Pinsky, L. (1993) · Nature Genetics · doi:10.1038/ng1093-184 · Cited by 357
Rennie, P. S. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.23 · Cited by 323
Reduced androgen receptor gene expression with first exon CAG repeat expansion
Choong, C. S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1527 · Cited by 310
Greenberg, N. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.2.230 · Cited by 267
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset
Hardy, D. O. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4400 · Cited by 247
Hsiao, P.-W., Lin, D.-L., Nakao, R., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20229 · Cited by 221
Hakimi, J. M., Schoenberg, M., Rondinelli, R. H., Piantadosi, S., & Barrack, E. R. (1997) · PubMed · Cited by 206
Transcriptional activation and transient expression of the human androgen receptor
Gao, T., Marcelli, M., & McPhaul, M. J. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00097-0 · Cited by 169
Claessens, F., Alen, P., Devos, A., Peeters, B., Verhoeven, G., & Rombauts, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19013 · Cited by 148
Kasper, S. F., Rennie, P. S., Bruchovsky, N., Sheppard, P. C., Cheng, H. W., Lin, L., Shiu, R. P. C., Snoek, R., & Matusik, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31761-7 · Cited by 139
Rundlett, S. E., Wu, X.-P., & Miesfeld, R. L. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-5-708 · Cited by 138
The N-terminal domain of the human androgen receptor is encoded by one, large exon
Faber, P. W., Kuiper, G. G. J. M., van Rooij, H. C. J., van der Korput, J. A. G. M., Brinkmann, A. O., & Trapman, J. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90137-8 · Cited by 134
The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
Giovannucci, E. L., Platz, E. A., Stampfer, M. J., Chan, A. T., Krithivas, K., Kawachi, I. I., Willett, W. C., & Kantoff, P. W. (1999) · Urology · doi:10.1016/s0090-4295(98)00468-3 · Cited by 128
Chamberlain, N. L., Whitacre, D. C., & Miesfeld, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26772 · Cited by 127
Jenster, G. W., de Ruiter, P. E., van der Korput, H. A. G. M., Kuiper, G. G. J. M., Trapman, J., & Brinkmann, A. O. (1994) · Biochemistry · doi:10.1021/bi00251a015 · Cited by 104
Characterization of an Expanded Glutamine Repeat Androgen Receptor in a Neuronal Cell Culture System
Brooks, B. P., Paulson, H. L., Merry, D. E., Salazar‐Grueso, E. F., Brinkmann, A. O., Wilson, E. M., & Fischbeck, K. H. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0126 · Cited by 88
Functional domains of the human androgen receptor
Jenster, G., van der Korput, J. A. G. M., Trapman, J., & Brinkmann, A. O. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90402-5 · Cited by 80
Hall, R. E., Tilley, W. D., McPhaul, M. J., & Sutherland, R. L. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520518 · Cited by 54
Gast, A., Neuschmid-Kaspar, F., Klocker, H., & Cato, A. C. B. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03554-k · Cited by 48
Brandes, L. J., & Hermonat, M. W. (1983) · PubMed · Cited by 47
Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy
Nakajima, H., Kimura, F., Nakagawa, T., Furutama, D., Shinoda, K., Shimizu, A., & Ohsawa, N. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00142-6 · Cited by 39
N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions
Gast, A., Schneikert, J., & Cato, A. C. B. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00176-3 · Cited by 27
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
Repeat instability: mechanisms of dynamic mutations
Pearson, C. E., Edamura, K. N., & Cleary, J. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1689 · Cited by 924
Andropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
“The length of trinucleotide CAG repeats in the androgen receptor gene is variable and is associated with differences in transcriptional activity, with a shorter CAG repeat length associated with greater androgen receptor activity and possibly overall greater androgen action (118).”
Background
Metadata
- Authors
- Beilin, J., Ball, E., Favaloro, J., & Zajac, J.
- Venue
- Journal of Molecular Endocrinology
- Publisher
- Bioscientifica
- Published
- 2000-08-01
- Volume
- 25
- Issue
- 1
- Pages
- 85-96
- ISSN
- 0952-5041 (ISSN-L)
- 1479-6813
- OpenAlex
- W2118184304
- Cited by
- 265
- References
- 44
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.